Effective treatment of kidney transplantation: A Synthesis of Findings from 15 Studies
- Home
- Effective treatment of kidney transplantation
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of kidney transplantation: A Synthesis of Findings from 15 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Key Research Findings
Kidney transplantation is the most effective treatment for patients with end-stage renal disease (ESRD). 3 It is associated with lower mortality and improved quality of life compared to dialysis. 4 However, kidney transplantation requires the use of immunosuppressive drugs to prevent rejection. 3 These drugs can have side effects, such as kidney damage and cardiovascular problems. 1 The optimal treatment for post-kidney transplant recipients is still under debate. 11
Live donor kidney transplantation is a common procedure, but it can cause subclinical acute kidney injury in donors. 8 Preoperative intravenous fluids may help to reduce this risk. 8
The increasing age of donors can lead to the diagnosis of a higher number of small renal masses (SRMs) which are most frequently renal cell carcinomas (RCCs). 9 A number of studies have reported their experience using kidneys with SRMs for transplantation. 9
Kidney transplantation is associated with longer survival and improved quality of life compared to dialysis. 15 However, patients with kidney failure often present with reduced cardiovascular reserve. 15
Treatment Summary
Standard protocols for kidney transplantation typically involve three drug groups, each directed to a site in the T-cell activation or proliferation cascade. 3 The three groups are: calcineurin inhibitors (e.g. cyclosporine, tacrolimus), anti-proliferative agents (e.g. azathioprine, mycophenolate mofetil), and steroids (prednisolone). 3 It remains unclear whether new regimens are more specific or simply more potent immunosuppressants. 3
Tacrolimus and cyclosporin are commonly used calcineurin inhibitors for kidney transplant recipients. 3 Azathioprine and mycophenolate mofetil are frequently used anti-proliferative agents in combination with calcineurin inhibitors. 3
Bisphosphonate and its supplements are used to treat bone loss in kidney transplant recipients. 11
Plasmapheresis is a treatment for antibody-mediated rejection in kidney transplant recipients. 10
Machine perfusion preservation and static cold storage are both methods for preserving kidneys for transplantation. 12
Benefits and Risks
Benefit Summary
Kidney transplantation is the optimal treatment for end-stage renal disease (ESRD) with longer survival and improved quality of life compared to dialysis. 4 Kidney transplantation is also associated with a reduced risk of cardiovascular events. 4
Risk Summary
Kidney transplantation can be associated with risks including rejection, surgical complications, and bone loss. 2 11 Long-term immunosuppressive therapy can also lead to side effects such as kidney damage and increased cardiovascular risk factors. 1
Comparison between Studies
Similarities
Many studies indicate that kidney transplantation is associated with lower mortality and improved quality of life compared to dialysis. 4 Many studies also indicate that immunosuppressive therapy can reduce rejection but has side effects such as kidney damage and cardiovascular problems. 3 1
Differences
Some studies compare the effectiveness and side effects of different immunosuppressive therapies. 3 7 Studies may also differ in their surgical methods and post-transplant management protocols.
Consistency and Contradictions
Many studies show that kidney transplantation improves survival and quality of life compared to dialysis. 4 However, results may vary depending on the type and dosage of immunosuppressive therapy used and the quality of the transplanted kidney. 3
Real-life Application
Kidney transplantation is an effective treatment for ESRD but faces challenges such as donor shortage. 14 Kidney transplantation is also an expensive procedure, creating a significant financial burden. 5
Limitations of Current Research
Kidney transplantation research faces various limitations, such as the difficulty of establishing causality in observational studies. 4 Furthermore, differences in patient backgrounds, treatment methods, and research protocols can make comparing results challenging.
Future Research Directions
Future research on kidney transplantation should focus on optimizing immunosuppressive therapies, addressing the donor shortage, and mitigating the financial burden associated with the procedure. 7 14 5
Conclusion
Kidney transplantation is an effective treatment for ESRD but involves risks such as rejection and surgical complications. 2 The decision to undergo transplantation should be made in consultation with a physician, considering individual patient health and risk factors. Appropriate care and management are crucial for those undergoing kidney transplantation. Efforts to increase donor availability and provide financial support are essential to promote wider adoption of kidney transplantation.
Treatment Keywords
calcineurin inhibitors, anti-proliferative agents, steroids, tacrolimus, cyclosporin, azathioprine, mycophenolate mofetil, prednisolone, bisphosphonate, plasmapheresis, machine perfusion preservation, static cold storage 3 8 11 10 12
Benefit Keywords
Risk Keywords
Article Type
Author: Smak GregoorP J, van GelderT, van BesouwN M, van der MastB J, IJzermansJ N, WeimarW
Language : English
Author: SteurerWolfgang, MalaiseJacques, MarkWalter, KoenigsrainerAlfred, MargreiterRaimund,
Language : English
Author: WebsterA, WoodroffeR C, TaylorR S, ChapmanJ R, CraigJ C
Language : English
Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.
Author: TonelliM, WiebeN, KnollG, BelloA, BrowneS, JadhavD, KlarenbachS, GillJ
Language : English
Author: GamboaO, MonteroC, MesaL, BenavidesC, ReinoA, TorresR E, CastilloJ S
Language : English
Author: Smith-PalmerJ, KalsekarA, ValentineW
Language : English
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
Author: WagnerMartin, EarleyAmy K, WebsterAngela C, SchmidChristopher H, BalkEthan M, UhligKatrin
Language : English
Author: MackinnonShona, AitkenEmma, GhitaRyan, ClancyMarc
Language : English
Author: HeviaVital, Hassan ZakriRhana, Fraser TaylorClaire, BruinsHarman Maxim, BoissierRomain, LledoEnrique, RegeleHeinz, BuddeKlemens, FigueiredoArnaldo, BredaAlberto, YuanCathy Yuhong, OlsburghJonathon
Language : English
Author: XiePan, TaoMin, PengKanfu, ZhaoHongwen, ZhangKeqin, ShengYuxiu, AnkawiGhada, RoncoClaudio
Language : English
Author: YangYan, QiuShi, DengLinghui, TangXi, LiXinrui, WeiQiang, FuPing
Language : English
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.
Author: TingleSamuel J, FigueiredoRodrigo S, MoirJohn Ag, GoodfellowMichael, TalbotDavid, WilsonColin H
Language : English
Author: KirkeskovLilli, CarlsenRasmus K, LundThomas, BuusNiels Henrik
Language : English
Author: ColomaLidia, CabelloRamiro, BuenoGonzalo, QuiciosCristina, García-CardosoJuan Vicente, González-EnguitaCarmen
Language : Spanish
Author: PellaEva, AlexandrouMaria-Eleni, BoutouAfroditi, TheodorakopoulouMarieta, DiplaKonstantina, ZafeiridisAndreas, SarafidisPantelis
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.